rs119103288
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000127.3(EXT1):c.1016G>T(p.Gly339Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G339D) has been classified as Pathogenic.
Frequency
Consequence
NM_000127.3 missense
Scores
Clinical Significance
Conservation
Publications
- exostoses, multiple, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
- chondrosarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- hereditary multiple osteochondromasInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EXT1 | ENST00000378204.7 | c.1016G>T | p.Gly339Val | missense_variant | Exon 2 of 11 | 1 | NM_000127.3 | ENSP00000367446.3 | ||
| EXT1 | ENST00000436216.2 | n.383G>T | non_coding_transcript_exon_variant | Exon 2 of 6 | 3 | ENSP00000400372.1 | ||||
| EXT1 | ENST00000684189.1 | n.483G>T | non_coding_transcript_exon_variant | Exon 2 of 11 | ||||||
| EXT1 | ENST00000437196.1 | n.74-1597G>T | intron_variant | Intron 1 of 9 | 5 | ENSP00000407299.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Multiple congenital exostosis Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly339 amino acid residue in EXT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9326317, 9620772, 10639137, 23439489; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EXT1 protein function. This missense change has been observed in individual(s) with multiple osteochondromas (PMID: 16088908; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 339 of the EXT1 protein (p.Gly339Val). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at